MedTrace Logo

Effects of Prostacyclin Infusion on Cerebral Vessels and Metabolism in Patients With Subarachnoid Haemorrhage

NCT01447095 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2014-07-21

No results posted yet for this study

Summary

The purpose of this study is to determine whether prostacyclin is effective in prevention of cerebral vasospasm in patients with subarachnoidal hemorrhage (SAH).

Conditions

  • Subarachnoid Hemorrhage

Interventions

DRUG

Prostacyclin 1 ng/kg/min

Continuous i.v. infusion of epoprostenol 1 ng/kg/min day 5-10 after SAH

DRUG

Prostacyclin 2 ng/kg/min

Continuous i.v. infusion of epoprostenol 2 ng/kg/min day 5-10 after SAH

DRUG

Placebo

Continuous i.v. infusion with placebo day 5-10 after SAH

Sponsors & Collaborators

  • Rune Rasmussen

    lead OTHER

Principal Investigators

  • Rune Rasmussen, MD · Rigshospitalet, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01447095 on ClinicalTrials.gov